Skip to content
Open access

Cholinergic contributions to speech-in-noise processing in Parkinson’s disease

Oct 2026 · Brain Communications · Vol 8 · 0 citations · 39 references
Medicine

TL;DR

These findings indicate that speech-in-noise deficits may reflect early subcortical and cortical cholinergic dysfunction rather than only peripheral auditory decline, and underscores the potential for cholinergic-enhancing or neurostimulation-based therapies to improve communication and cognitive outcomes in neurodegenerative disorders.

Abstract

Abstract Speech perception performance in challenging listening environments declines with age and is particularly impaired in Parkinson’s disease, leading to communication difficulties and cognitive strain. Although peripheral hearing loss contributes to these deficits, dysfunction of the central cholinergic system may play a key role. Parkinson’s disease is characterized by early and widespread cholinergic degeneration. Accordingly, further describing the contribution of cholinergic integrity to functional hearing may offer better insight into the mechanistic link between sensory and cognitive decline and inform targeted therapeutic approaches. Twenty-nine individuals with Parkinson’s disease (20 men, nine women; age range 60–76 years) were enrolled in a cross-sectional study conducted at the University of Michigan Functional Neuroimaging, Cognitive and Mobility Laboratory. Participants completed pure-tone audiometry, tympanometry and Quick Speech-in-Noise testing to assess peripheral and functional hearing. Cholinergic system integrity was quantified using [18F]-fluoroethoxybenzovesamicol [18F]-FEOBV positron emission tomography imaging, and magnetic resonance imaging was used for anatomical co-registration. Statistical parametric mapping identified regions where cholinergic binding correlated with speech-in-noise performance after adjusting for high-frequency pure-tone average thresholds. Multiple regression and hierarchical model comparisons tested independent and interactive effects of peripheral hearing and cholinergic integrity. High-frequency pure-tone average explained 21.6% of the variance in Quick Speech-in-Noise signal-to-noise ratio loss [β = 0.494 (0.151–0.838), P = 0.006]. After adjustment for hearing thresholds, reduced [18F]-FEOBV binding in auditory, thalamic, temporoparietal and cerebellar regions was significantly associated with greater signal-to-noise ratio loss (cluster-level family-wise error corrected P < 0.01). Cholinergic integrity accounted for an additional 27.5% of the variance beyond peripheral hearing [F = 15.596, P < 0.001; β = −0.533 (−0.811 to −0.256), P = 0.001]. An interaction between hearing thresholds and cholinergic integrity explained a further 12.7% of the variance (F = 9.671, P = 0.005), showing that higher cholinergic integrity mitigated the detrimental effects of hearing loss on speech-in-noise understanding. Observed effects were found to be independent of age and global cognition in the post hoc confounder regression analysis. Central cholinergic integrity is a major determinant of speech-in-noise performance in Parkinson’s disease, acting both independently and interactively with peripheral hearing function. These findings indicate that speech-in-noise deficits may reflect early subcortical and cortical cholinergic dysfunction rather than only peripheral auditory decline. Recognition of this relationship underscores the potential for cholinergic-enhancing or neurostimulation-based therapies to improve communication and cognitive outcomes in neurodegenerative disorders.

Read PDF

Similar papers

Open access Sep 2026

Study of speech perception in noise (SPIN) test and gap in noise (GIN) test in mild cognitive impairment in adult

Both SPIN and GIN performances were reduced in patients with MCI, but the SPIN test demonstrated superior diagnostic performance and may serve as a useful screening tool for early detection of MCI, whereas the GIN test has limited value as a standalone screening measure.

Amal Elsebaie Beshr, Iman Ibrahim Eladawy, Safaa Mahmoud Hammouda et al. · 0 citations
Open access Oct 2026

Relationships between extended high frequency hearing, cognition, and speech-in-noise performance

Findings are consistent with previous literature and support the clinical relevance of EHF sensitivity, which is found to be a stronger predictor of speech in-noise performance, despite limited EHF spectral information in the WIN stimuli.

Claire M. Dorey, D. Eddins, A. Eddins et al. · 0 citations
Open access Nov 2026

Subjective and objective central auditory assessment in patients with multiple sclerosis: a case-control study

A combined behavioral and electrophysiological auditory test battery can help identify brainstem and cortical pathway involvement and may support more targeted clinical management of listening complaints in MS.

Nora Ahmed Saleh, Elshahat Ibrahem Ismail, Tamer Belal et al. · 0 citations
Open access Oct 2026

Striatal network dysfunction underlying speech impairment in early Parkinson’s disease

The pathophysiology underlying Parkinson’s disease (PD) speech impairments and its potential sex differences remain unclear. We investigated sex-specific alterations in speech and striato-cortical networks in 104 patients with early PD (68M/36F), and 44 healthy controls (23M/21F), using quantitative speech markers and...

Caitlin Paige Rogers, Sandy Mournet, C. Galléa et al. · 0 citations
Open access Sep 2026

Distinct Roles of Working Memory and Inhibitory Control in Speech-in-Noise Perception

Difficulty perceiving speech in noise is the primary complaint of patients seeking hearing healthcare, even absent overt losses in audiometric thresholds. Yet current clinical practice largely focuses on sensory function while ignoring the potentially outsized effects of executive function on everyday suprathreshold li...

Sharadhi Bharadwaj, Catherine Dymowski, Erin Batik et al. · 0 citations
Open access Oct 2026

Spectrotemporal Processing Using the Spectral-Temporally Modulated Ripple Test and Its Relation to Cognition and Hearing Loss in Adults.

Nonsignificant interactions suggest that the neurocognitive effects on SMRT are constant across degrees of hearing loss, and support ongoing use of SMRT in middle-aged and older adults with hearing loss, although the independent effects of neurocognitive functions should be accounted for when interpreting SMRT performa...

Michael R. Papazian, Katelyn A. Berg, A. DeFreese et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.